Observational studyEuropean journal of nutrition2026
Plasma amino acids in early pregnancy and fetal growth trajectories across pregnancy: findings from a multi-racial U.S. pregnancy cohort.
Observational study in European journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00912132 (The National Standard for Normal Fetal Growth), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The National Standard for Normal Fetal Growth
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
purposeAmino acids (AA) are crucial for fetal growth, but their associations are not fully understood. We examined the associations of plasma AAs in early pregnancy with fetal growth trajectories across pregnancy.
methods321 women from a GDM nested case-control study from the Eunice Kennedy Shriver NICHD Fetal Growth Studies were enrolled at 10-14 gestational weeks. Ultrasound schedules were randomly assigned to estimate weekly fetal growth. Plasma concentrations of aromatic AAs, branched-chain AAs, and AAs involved in one-carbon metabolism were measured using blood samples collected at enrollment. We modeled fetal growth trajectories across AA tertiles with cubic splines using linear mixed models, accounting for major confounders; global differences were tested using log-likelihood ratio tests. Then, we performed weekly comparisons of fetal growth parameters between AA tertiles to evaluate the trajectory of fetal growth parameters.
resultsIn global tests, AAs were associated with fetal growth trajectories. In weekly comparisons, for instance, women with the highest tertile of methionine had lower estimated fetal weight (EFW) and biparietal diameter (BPD) in mid-pregnancy (EFW at week 27: 992.65 vs. 1050.72 g, p-value = 0.04, overall linear p-trend = 0.03; BPD at week 22: 51.90 vs. 54.06 mm, p-value < 0.0001, overall linear p-trend = 0.007), compared to the lowest tertile. The highest tertile of tyrosine was associated with lower BPD in mid-to-late pregnancy (BPD at week 20: 46.38 vs. 48.26 mm, p-value = 0.005, at week 31: 77.08 vs. 79.52 mm, p-value = 0.005, overall linear p-trend = 0.02).
conclusionsOverall, plasma AAs were inversely related to subsequent fetal growth trajectories, with differences observed by AAs and gestational age. TRIAL REGISTRATION NUMBER: NCT00912132.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.